Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24103647)

1.

The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum.

Urrutia A, Granado N, Gutierrez-Lopez MD, Moratalla R, O'Shea E, Colado MI.

Int J Neuropsychopharmacol. 2014 Feb;17(2):235-46. doi: 10.1017/S1461145713000850. Epub 2013 Oct 8.

PMID:
24103647
2.

The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum.

Sanchez V, Zeini M, Camarero J, O'Shea E, Bosca L, Green AR, Colado MI.

J Neurochem. 2003 Apr;85(2):515-24.

PMID:
12675928
3.

Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Granado N, Ares-Santos S, O'Shea E, Vicario-Abejón C, Colado MI, Moratalla R.

Neurotox Res. 2010 Jul;18(1):48-58. doi: 10.1007/s12640-009-9106-1. Epub 2009 Sep 4.

4.

A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine.

Urrutia A, Rubio-Araiz A, Gutierrez-Lopez MD, ElAli A, Hermann DM, O'Shea E, Colado MI.

Neurobiol Dis. 2013 Feb;50:49-58. doi: 10.1016/j.nbd.2012.10.006. Epub 2012 Oct 12.

PMID:
23069681
5.

Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.

Itzhak Y, Gandia C, Huang PL, Ali SF.

J Pharmacol Exp Ther. 1998 Mar;284(3):1040-7.

6.

Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

Zhu JP, Xu W, Angulo JA.

Neuroscience. 2006 Jun 30;140(2):607-22. Epub 2006 May 2.

8.
9.

Protein phosphorylation cascades associated with methamphetamine-induced glial activation.

Hebert MA, O'Callaghan JP.

Ann N Y Acad Sci. 2000 Sep;914:238-62.

PMID:
11085325
10.

Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells.

Wang SF, Yen JC, Yin PH, Chi CW, Lee HC.

Toxicology. 2008 Apr 18;246(2-3):234-41. doi: 10.1016/j.tox.2008.01.020. Epub 2008 Feb 6.

PMID:
18325654
11.

Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity.

Chan P, Di Monte DA, Luo JJ, DeLanney LE, Irwin I, Langston JW.

J Neurochem. 1994 Jun;62(6):2484-7.

PMID:
8189253
12.

Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.

Granado N, Lastres-Becker I, Ares-Santos S, Oliva I, Martin E, Cuadrado A, Moratalla R.

Glia. 2011 Dec;59(12):1850-63. doi: 10.1002/glia.21229. Epub 2011 Aug 31.

PMID:
21882243
13.

The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice.

Zhu J, Xu W, Wang J, Ali SF, Angulo JA.

J Neurochem. 2009 Nov;111(3):656-68. doi: 10.1111/j.1471-4159.2009.06330.x. Epub 2009 Aug 13.

14.

The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Afanador L, Mexhitaj I, Diaz C, Ordonez D, Baker L, Angulo JA.

Brain Res. 2013 May 13;1510:38-47. doi: 10.1016/j.brainres.2013.03.010. Epub 2013 Mar 19.

15.

Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.

Kita T, Paku S, Takahashi M, Kubo K, Wagner GC, Nakashima T.

Neuropharmacology. 1998 Sep;37(9):1177-84.

PMID:
9833648
16.

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.

Neurobiol Dis. 2011 Jun;42(3):391-403. doi: 10.1016/j.nbd.2011.01.033. Epub 2011 Feb 15.

PMID:
21303698
18.
19.

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.

McFadden LM, Hadlock GC, Allen SC, Vieira-Brock PL, Stout KA, Ellis JD, Hoonakker AJ, Andrenyak DM, Nielsen SM, Wilkins DG, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2012 Feb;340(2):295-303. doi: 10.1124/jpet.111.188433. Epub 2011 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk